Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
収録刊行物
-
- The Lancet
-
The Lancet 397 (10279), 1063-1074, 2021-03
Elsevier BV